These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28124229)

  • 1. The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.
    Yang J; Yang H; Li Z; Lin H; Zhao Y; Wang W; Tan S; Zeng X; Li Y
    Protein Cell; 2017 Mar; 8(3):225-229. PubMed ID: 28124229
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.
    Konishi E; Konishi M
    Jpn J Infect Dis; 2011; 64(4):284-91. PubMed ID: 21788702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.
    Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
    Vaccine; 2001 Feb; 19(13-14):1753-63. PubMed ID: 11166901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.
    Mathenge EGM; Parquet MDC; Funakoshi Y; Houhara S; Wong PF; Ichinose A; Hasebe F; Inoue S; Morita K
    J Gen Virol; 2004 Sep; 85(Pt 9):2503-2513. PubMed ID: 15302944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.
    Yang H; Li Z; Lin H; Wang W; Yang J; Liu L; Zeng X; Wu Y; Yu Y; Li Y
    Arch Virol; 2016 Jun; 161(6):1517-26. PubMed ID: 26976137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines aplenty.
    Halstead SB
    Curr Opin Infect Dis; 2002 Oct; 15(5):461-3. PubMed ID: 12686876
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
    Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
    Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice.
    Konishi E; Terazawa A; Fujii A
    Vaccine; 2003 Sep; 21(25-26):3713-20. PubMed ID: 12922102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Immunol; 1988 Nov; 141(10):3606-10. PubMed ID: 2460542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
    Saluzzo JF
    Adv Virus Res; 2003; 61():419-43. PubMed ID: 14714439
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-positivity of anti-dengue virus and anti-Japanese encephalitis virus IgM in endemic area: co-infection or cross reactivity?
    Singh KP; Mishra G; Jain P; Pandey N; Nagar R; Gupta S; Prakash S; Prakash O; Khan DN; Shrivastav S; Singh DD; Jain A
    Asian Pac J Trop Med; 2014 Feb; 7(2):124-9. PubMed ID: 24461525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice.
    Konishi E; Terazawa A; Imoto J
    Vaccine; 2003 May; 21(17-18):1826-32. PubMed ID: 12706666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
    Yasuda A; Kimura-Kuroda J; Ogimoto M; Miyamoto M; Sata T; Sato T; Takamura C; Kurata T; Kojima A; Yasui K
    J Virol; 1990 Jun; 64(6):2788-95. PubMed ID: 2159544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
    Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
    Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vectors expressing chimeric Japanese encephalitis dengue 2 viruses.
    Wei Y; Wang S; Wang X
    Acta Virol; 2014; 58(4):340-7. PubMed ID: 25518715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.